Alterações cognitivas e do sono na síndrome pós-COVID-19
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Resumo
Objetivos: Avaliar as principais alterações na cognição e no sono em pacientes com síndrome pós-COVID-19. Métodos: Estudo analítico transversal. Foram avaliados 51 pacientes, maiores de 18 anos com síndrome pós-COVID-19 com queixas cognitivas e do sono através de um formulário autoral e de questionários validados para cognição (MoCA e MoCA-B) e para o sono (Escala de sonolência de Epworth, Índice de qualidade do sono de Pittsburgh, Questionário de perturbação do sono e Índice de gravidade de insônia). Resultados: Na amostra avaliada predominou o sexo feminino (80,4%), com idade de 59,9 anos apresentando gravidade da COVID-19 leve (52,9%). As queixas neurocognitivas (90,2%) e do sono (96,1%) foram prevalentes, ocorrendo independentemente da gravidade da doença. Na cognição predominou alterações na memória de curto prazo e no sono, a sonolência e a fadiga. Nos testes MoCA e MoCA-B, 81,57% apresentaram comprometimento cognitivo leve. Os testes de sono mostraram impactos na qualidade e quantidade de sono, sem correlação significante entre os testes de distúrbios do sono e os de cognição agrupados. Conclusão: Os impactos na cognição e no sono na síndrome pós-COVID-19 devem ser foco de atenção das equipes de saúde que realizam intervenções nesta população pois são prevalentes e podem ocasionar prejuízos biopsicossociais.
##plugins.themes.bootstrap3.article.details##
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Referências
2. ANAYA JM, et al. Post-COVID syndrome. A case series and comprehensive review. Autoimmunity reviews, 2021; 20(11): 102947.
3. BERTUCCELLI M, et al. Cognitive impairment in people with previous COVID-19 infection: A scoping review. Cortex; a journal devoted to the study of the nervous system and behavior, 2022; 154: 212-230.
4. CIPOLLI GC, et al. Cognitive impairment in post-acute COVID-19 syndrome: a scoping review. Arquivos de neuropsiquiatria, 2023; 81(12): 1053-1069.
5. CRIVELLI L, et al. Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis. Alzheimer's & dementia: the journal of the Alzheimer's Association, 2022; 18(5): 1047-1066.
6. DAMIANO RF, et al. Association between chemosensory impairment with neuropsychiatric morbidity in post-acute COVID-19 syndrome: results from a multidisciplinary cohort study. European archives of psychiatry and clinical neuroscience, 2023; 273(2): 325-333.
7. GOMES LPOZ, et al. Neurological and neuropsychiatric manifestations of post-COVID-19 condition in South America: a systematic review of the literature. Arquivos de neuropsiquiatria, 2024; 82(1): 1-8.
8. IDA FS, et al. Post-COVID-19 syndrome: persistent symptoms, functional impact, quality of life, return to work, and indirect costs - a prospective case study 12 months after COVID-19 infection. Cadernos de saude publica, 2024; 40(2): e00022623.
9. JAHRAMI H, et al. Sleep problems during the COVID-19 pandemic by population: a systematic review and meta-analysis. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine, 2021; 17(2): 299-313.
10. JAROSCH I, et al. Impaired Sleep in Patients with Post-COVID-19 Syndrome Compared to Healthy Controls: A Cross-Sectional Trial. Respiration; international review of thoracic diseases, 2024, 103(4): 177-181.
11. MARTIN EM, et al. Persistent cognitive slowing in post-COVID patients: longitudinal study over 6 months. Journal of neurology, 2024; 271(1): 46-58.
12. MILL JG, POLESE J. Post-COVID Syndrome or Long COVID: A New Challenge for the Healthcare System. Síndrome Pós-COVID ou COVID Longa: Um Novo Desafio para o Sistema de Saúde. Arquivos brasileiros de cardiologia, 2023; 120(11): e20230750.
13. MONJE M, IWASAKI A. The neurobiology of long COVID. Neuron, 2022; 110(21): 3484-3496.
14. NALBANDIAN A, et al. Post-acute COVID-19 syndrome. Nature medicine, 2021; 27(4): 601-615.
15. NICOTRA A, et al. What do we mean by long COVID? A scoping review of the cognitive sequelae of SARS-CoV-2 infection. European journal of neurology, 2023; 30(12): 3968-3978.
16. ONYEAKA H, et al. COVID-19 pandemic: A review of the global lockdown and its far-reaching effects. Science progress, 2021; 104(2): 368504211019854.
17. PAI N, VELLA SL. The physical and mental health consequences of social isolation and loneliness in the context of COVID-19. Current opinion in psychiatry, 2022; 35(5): 305-310.
18. PELLITTERI G, et al. Sleep alterations following COVID-19 are associated with both neuroinflammation and psychological disorders, although at different times. Frontiers in neurology, 2022; 13: 929480.
19. PERCZE AR, et al. Fatigue, sleepiness and sleep quality are SARS-CoV-2 variant independent in patients with long COVID symptoms. Inflammopharmacology, 2023; 1-7.
20. PREMRAJ L, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. Journal of the neurological sciences, 2022; 434: 120162.
21. RAVEENDRAN AV, et al. Long COVID: An overview. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 15(3): 869-875.
22. SCHILLING C, et al. Kognitive Störungen und Schlafstörungen bei Long-COVID. Der Nervenarzt, 2022; 93(8): 779-787.
23. STEFANO GB, et al. Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce 'Brain Fog' and Results in Behavioral Changes that Favor Viral Survival. Medical science monitor: international medical journal of experimental and clinical research, 2021; 27: e930886.
24. STEFANO GB. Historical Insight into Infections and Disorders Associated with Neurological and Psychiatric Sequelae Similar to Long COVID. Medical science monitor: international medical journal of experimental and clinical research, 2021; 27: e931447.
25. WOO MS, et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain communications, 2020; 2(2): fcaa205.
26. XIONG J, et al. Impact of COVID-19 pandemic on mental health in the general population: A systematic review. Journal of affective disorders, 2020; 277: 55-64.
27. XU E, et al. Long-term neurologic outcomes of COVID-19. Nature medicine, 2022; 28(11): 2406-2415.
28. ZIFKO U, et al. Management of cognitive impairment associated with post-COVID-19 syndrome: recommendations for primary care. Frontiers in pharmacology, 2024; 15: 1338235.
29. ZÜLKE AE, et al. Cognitive performance in adults with post-COVID syndrome: Results from a German case-control study. Journal of Psychiatric Research, 2024; 176: 377-383.